Delivery Order SPE2DB20D2104-SPE2DB25FMWLD
Award Date 7/24/25
Potential Completion Date 7/25/25
Potential Value $1.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,045.10 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 8 mg tablets in unit dose packages of 100 units. The contract is firm fixed price, non-competitive set-aside, with an ultimate completion date of August 18, 2025. Performance will occur at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,544.42 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets (30-count package) on July 29, 2025, with completion targeted for July 30, 2025. This competitive award—utilizing firm fixed pricing with no set-aside designation—represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The product will be delivered to the company's...
- The Defense Logistics Agency awarded a delivery order valued at $5,255.69 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 8 mg tablets (30-count) on May 9, 2025, with completion scheduled for May 12, 2025. This competitive, non-set-aside contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,403.28 to AmerisourceBergen Drug Corp for the supply of Ondansetron HCL 8 mg tablets (30-count) on September 11, 2025, with an ultimate completion date of September 12, 2025. This firm fixed-price, non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on September 16, 2025, for Ondansetron HCL 8 mg tablets (30-count packaging) with a ceiling value of $100,030.94. This competitively awarded, firm fixed price delivery order represents a non-set-aside procurement and is scheduled for completion by September 17, 2025, with performance at the awardee's Conshohocken, Pennsylvania location. The contract is issued as a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order on September 4, 2025, for Ondansetron ODT 8 mg tablets (30-count) with a ceiling value of $3,208.01. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of September 5, 2025. The order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child action under...
- The Defense Logistics Agency awarded a $29,480.06 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets (30-count packages) on September 3, 2025, with completion scheduled for September 4, 2025. This non-set-aside contract was competitively awarded and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The...
- The Defense Logistics Agency awarded a $17,662.48 delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count package) on August 19, 2025, with an ultimate completion date of August 20, 2025. This competitive, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 and extends through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $27,766.85 to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count supply) on August 12, 2025, with an ultimate completion date of August 13, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $5,636.06 for Ondansetron ODT 8 mg tablets (30-count supply) on July 29, 2025, with completion expected by July 30, 2025. This firm fixed-price, competitively awarded contract (no set-aside used) represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is located at the...